Cargando…
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
High molecular group box 1 (HMGB1) is a highly conserved member of the HMG-box-family; abundantly expressed in almost all human cells and released in apoptosis; necrosis or by activated immune cells. Once in the extracellular space, HMGB1 can act as a danger associated molecular pattern (DAMP), thus...
Autores principales: | Pilzweger, Christin, Holdenrieder, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665591/ https://www.ncbi.nlm.nih.gov/pubmed/26854151 http://dx.doi.org/10.3390/diagnostics5020219 |
Ejemplares similares
-
Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies
por: Schröder, Lars, et al.
Publicado: (2023) -
The Immune Tolerance Role of the HMGB1-RAGE Axis
por: Watanabe, Haruki, et al.
Publicado: (2021) -
Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
por: Singh, Harbinder, et al.
Publicado: (2022) -
Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020) -
Mechanism of HMGB1–RAGE in Kawasaki disease with coronary artery injury
por: Qian, Biying, et al.
Publicado: (2020)